Ethnicity, race, and baseline retinopathy correlates in the Veterans Affairs Diabetes Trial

Diabetes Care

Volumn 28, Issue 8, 2005, Pages 1954-1958

  Emanuele, Nicholas ^a   Sacks, Jerome ^b   Klein, Ronald ^c   Reda, Domenic ^b   Anderson, Robert ^d   Duckworth, William ^e   Abraira, Carlos ^f  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

^d VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^e CARL T HAYDEN VA MEDICAL CENTER   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; AGE DISTRIBUTION; AMPUTATION; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ETHNIC DIFFERENCE; ETHNOLOGY; FEMALE; HEART MUSCLE REVASCULARIZATION; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTICENTER STUDY; OPHTHALMOSCOPY; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; SMOKING; SOLDIER; STATISTICAL SIGNIFICANCE; STROKE; SYSTOLIC BLOOD PRESSURE;

ADULT; AFRICAN AMERICANS; BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; CONTINENTAL POPULATION GROUPS; DIABETIC RETINOPATHY; ETHNIC GROUPS; HEMOGLOBIN A, GLYCOSYLATED; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES; UNITED STATES; VETERANS;

EID: 23044433655     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.8.1954     Document Type: Article

References (27)

1. UK Perspective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
2. Ohkubo Y, Kishikawa H, Araki E: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res and Clin Pract 28:103-117, 1995
3. Diabetes Control and Complications Trial Research Group (DCCT): The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-994, 1993
4. Abraira C, Duckworth W, McCarren M, Emanuele N, Area D, Reda D, Henderson W: Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2 (Veterans Affairs Diabetes Trial). J Diabetes Compl 17:314-322, 2003
5. Emanuele N, Klein R, Abraira C, Colwell J, Comstock J, Henderson WG, Levin S, Nuttall F, Sawin C, Silbert C, Lee HS, Johnson-Nagel N: Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): a feasibility study. Diabetes Care 19:1375-1381, 1996
6. Reaven PD, Sacks J, VADT Investigators: Reduced coronary and abdominal artery calcification in Hispanics with type 2 diabetes. Diabetes Care 27:1115-1120, 2004
7. Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD: Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? Diabetes Care 21:1230-1235, 1998
8. Haffner SM, Fong D, Stern M, Pugh J, Hazuda H, Patterson J, van Heuven W, Klein R: Diabetic retinopathy in Mexican Americans and Non-Hispanic whites. Diabetes 37:878-884, 1988
9. The Eye Disease Prevalence Research Group: The prevalence of diabetic retinopathy among adults in the United. States. Arch Ophthalmol 122:552-563, 2004
10. Tudor SM, Hamman RF, Baron A, Johnson DW, Shetterly SM: Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with type 2 diabetes: San Luis Valley Diabetes Study, Colorado. Diabetes Care 21:53-61, 1998
11. Hamman RF, Mayer EJ, Moo-Young GA, Hilderbrandt W, Marshall JA, Baxter J: Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM: San Luis Valley Diabetes Study. Diabetes 38:1231-1237, 1989
12. West SK, Klein R, Rodriguez J, Beatriz M, Broman MS, Rosario S, Snyder R: Diabetes and diabetic retinopathy in a Mexican-American population. Diabetes Care 24: 1204-1209, 2001
13. Harris EL, Feldman S, Robinson CR, Sherman S, Georgopoulos A: Racial differences in the relationship between blood pressure and the risk of retinopathy among individuals with NIDDM. Diabetes Care 16:748-754, 1993
14. Harris EL, Sherman SH, Georgopoulos A: Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes. Diabetes Care 22:779-783, 1999
15. Mansfield MW, Grant PJ: Fibrinolysis and diabetic retinopathy in NIDDM. Diabetes Care 18:1577-1581, 1995
16. Cho YW, Yang DH, OH DY, Baick SH, Kim SK, Kim SH, Hong SY: Plasma t-PA and PAI-1 antigen concentration in non-insulin dependent diabetic patients: implication for diabetic retinopathy. Diabetes Res Clin Pract 22:123-128, 1994
17. Vekasi J, Marton ZS, Kesmarky G, Cser A, Russai R, Horvath B: Hemorheological alterations in patients with diabetic retinopathy. Clin Remarked Microcirc 24:59-64, 2001
18. Asakawa H, Tokunaga K, Kawakami F: Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J Diabetes Complications 14:121-126, 2000
19. Brown JB, Pedula KL Summers KH: Diabetic retinopathy: contemporary prevalence in a well-controlled population. Diabetes Care 26:2637-2642, 2003
20. Klein R: Diabetes mellitus: oculopathy. In Endocrinology. 4th ed. DeGroot L, Jameson JL, Eds. Philadelphia, WB Saunders, 2001, p. 857-867
21. Schrier RW, Estacio RO, Esler A, Mehler P: Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria retinopathy, and strokes. Kidney Int 61:1066-1097, 2002
22. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br Med J 317:703-713, 1998
23. Anderson R, Abraira C, Duckworth W, McCarren M, Zimering M, Veterans Affairs Diabetes Trial (VADT) Group: Blood pressure (BP) control in the VADT. Presented at the Endocrine Society 85th Annual Meeting, 19-22 June 2003, Philadelphia, Pennsylvania, p. 750
24. Chew EY, Klein ML, Ferris FL, Remaley NA, Murphy RP, Chantree K: The association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol 114:1079-1084, 1996
25. Klein BE, Moss SE, Klein R, Surawicz TS: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy in hard exudate. Ophthalmology 98:1261-1265, 1991
26. Kirkman MS, McCarren M, Duckworth W, Abraira C, VADT Group: Cardiovascular disease correlates with traditional risk factors but not with glycemic control in established type 2 diabetes (Abstract). Diabetes 53 (Suppl. 2):A77, 2004
27. Abraira C, Duckworth W: The need for glycemic trials in type 2 diabetes. Clin Diabetes 21:107-111, 2003